Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
about
Hib Vaccines: Past, Present, and Future PerspectivesPhase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccineProduction of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.Glycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses.Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine.Realizing the Promise of Chemical Glycobiology.Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.Towards the next generation of biomedicines by site-selective conjugation.Implications of plant glycans in the development of innovative vaccines.O-antigen polymerase adopts a distributive mechanism for lipopolysaccharide biosynthesis.Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli.In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q26767144-9F2C21C4-32A6-4192-8C78-E64A6345F68CQ33666510-789ED372-C83A-4064-8FF1-789547CCD4FCQ33965527-D701616B-C82B-47A8-9377-DFE5ADCB63B1Q34066431-2F43B762-3534-426A-BF83-9CF39CDA63B2Q36933800-9A622A36-23ED-464F-947D-707D432935B7Q37063821-3AAECA84-2880-477F-A6ED-3B650B10388BQ37719754-258FA3ED-57AE-45EE-A547-A942CF6B1294Q38300058-7A828F51-0B67-4C24-8E69-C7C96130255CQ38706553-7CC2D379-D276-4AF3-B744-EBCC439297E9Q38738762-01D2C287-20D9-4640-929C-C5208A393EB3Q38794437-6F1975BC-BB9D-4995-BBD6-C57EDFF2A01EQ41008205-E8EF5CCD-E0CB-4E5C-AD46-34D0FE5D4BDBQ42120657-990B9AF4-90F3-4432-B5AF-2B3D9014D068Q53701548-4A6D88FB-8055-40A3-8C22-FA728B45B068
P2860
Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Engineering, conjugation, and ...... s a typhoid vaccine component.
@en
type
label
Engineering, conjugation, and ...... s a typhoid vaccine component.
@en
prefLabel
Engineering, conjugation, and ...... s a typhoid vaccine component.
@en
P2093
P2860
P1476
Engineering, conjugation, and ...... s a typhoid vaccine component.
@en
P2093
Michael Kowarik
Michael Steffen
Michael Wacker
Michael Wetter
Paula Carranza
P2860
P2888
P304
P356
10.1007/S10719-012-9451-9
P577
2012-10-06T00:00:00Z
P5875
P6179
1027428665